Nanobiotix S.A. American Depositary Shares
Symbol: NBTX (NASDAQ)
19.27
▼ (-0.08%) -0.015
Company Description:
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Key Stats
- Today's Open: $19.15
- Today's High: $20.713
- Today's Low: $18.201
- Today's Volume: 176.92K
- Yesterday Close: $19.28
- Yesterday High: $20.92
- Yesterday Low: $18.925
- Yesterday Volume: 161.33K
- Last Min Volume: 0
- Last Min High: $19.265
- Last Min Low: $19.265
- Last Min VWAP: $0
Company Profile
- Name: Nanobiotix S.A. American Depositary Shares
- Website: https://www.nanobiotix.com
- Listed Date: 2020-12-11
- Location: ,
- Market Status: Active
- CIK Number: 0001760854
- SIC Code:
- SIC description:
- Market Cap: $925.73M
- Round Lot: 100
- Outstanding Shares: 48.22M
- Asset Type: ADRC
RECENT FILINGS FOR NBTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-24 | 6-K | View |
| 2025-10-15 | 6-K | View |
| 2025-10-01 | 6-K | View |
| 2025-09-30 | 6-K | View |
| 2025-09-30 | 6-K | View |
| 2025-09-30 | 6-K | View |
| 2025-09-17 | 6-K | View |
| 2025-09-12 | 6-K | View |
| 2025-09-02 | 6-K | View |
| 2025-08-27 | 6-K | View |
| 2025-07-11 | 6-K | View |
| 2025-07-02 | 6-K | View |
| 2025-06-10 | 6-K | View |
| 2025-05-28 | 6-K | View |
| 2025-05-27 | 6-K | View |
| 2025-05-27 | 6-K | View |
| 2025-05-21 | 6-K | View |
| 2025-05-15 | 6-K | View |
| 2025-05-14 | S-8 | View |
| 2025-05-14 | 6-K | View |
Latest News on NBTX